HTS106M Sigma-AldrichChemiSCREEN™ Membrane Preparation Recombinant Human MT2 Melatonin Receptor
Human MT2 GPCR membrane preparation for Radioligand binding Assays & GTPγS binding.
More>> Human MT2 GPCR membrane preparation for Radioligand binding Assays & GTPγS binding. Less<<Prodotti consigliati
Panoramica
Replacement Information |
---|
Tabella delle specifiche principali
Species | Host Cells | Protein Target |
---|---|---|
Human | Chem-1 | MT2 |
References |
---|
Product Information | |
---|---|
Format | Membranes |
Presentation | Liquid in packaging buffer: 50 mM Tris pH 7.4, 10% glycerol and 1% BSA with no preservatives. Packaging method: Membranes protein were adjusted to 1 mg/mL in packaging buffer, and dispensed at 1 mL/vial. Vials were rapidly frozen, and stored at -80°C. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Maintain frozen at -70°C for up to 2 years. Do not freeze and thaw. |
Packaging Information | |
---|---|
Material Size | 200 units |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Numero di catalogo | GTIN |
HTS106M | 04053252735462 |
Documentation
Riferimenti bibliografici
Panoramica dei riferimenti bibliografici | Codice d'identificazione nel Pub Med |
---|---|
Melatonin receptor signaling: finding the path through the dark Masana, M I and Dubocovich, M L Sci STKE, 2001:PE39 (2001) 2001 | 11698691 |
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms Dubocovich, M L, et al FASEB J, 12:1211-20 (1998) 1998 | 9737724 |
Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor Dubocovich, M L, et al Naunyn Schmiedebergs Arch Pharmacol, 355:365-75 (1997) 1997 | 9089668 |